Clinical trials
Phase 1 Multiple Myeloma trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Completed | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 6 |
| Genentech, Inc. | 3 |
| Novartis Pharmaceuticals | 3 |
| Hadassah Medical Organization | 2 |
| Janssen Research & Development, LLC | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Celgene | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 24 |
| Neoplasms | 5 |
| Recurrence | 4 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Amyloidosis | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Smoldering Multiple Myeloma | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.